POLYVALENT MELANOMA VACCINE IMPROVES SURVIVAL OF PATIENTS WITH METASTATIC MELANOMA

被引：0
|
作者：
MORTON, DL [1 ]
HOON, DSB [1 ]
NIZZE, JA [1 ]
FOSHAG, LJ [1 ]
FAMATIGA, E [1 ]
WANEK, LA [1 ]
CHANG, C [1 ]
IRIE, RF [1 ]
GUPTA, RK [1 ]
ELASHOFF, R [1 ]
机构：
[1] ST JOHNS HOSP, SANTA MONICA, CA 90404 USA
来源：
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES | 1993年 / 690卷
关键词：
D O I：
暂无
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：120 / 134
页数：15
相关论文
共 50 条
  • [21] Active specific immunotherapy with polyvalent melanoma cell vaccine for patients with in-transit melanoma metastases
    Hsueh, EC
    Nathanson, L
    Foshag, LJ
    Essner, R
    Nizze, JA
    Stern, SL
    Morton, DL
    CANCER, 1999, 85 (10) : 2160 - 2169
  • [22] IDENTIFICATION OF IMMUNOGENIC HUMAN-MELANOMA ANTIGENS IN A POLYVALENT MELANOMA VACCINE
    BYSTRYN, JC
    HENN, M
    LI, J
    SHROBA, S
    CANCER RESEARCH, 1992, 52 (21) : 5948 - 5953
  • [23] Survivin expression by metastatic melanoma predicts poor disease outcome in patients receiving adjuvant polyvalent vaccine
    Takeuchi, H
    Morton, DL
    Elashoff, D
    Hoon, DSB
    INTERNATIONAL JOURNAL OF CANCER, 2005, 117 (06) : 1032 - 1038
  • [24] IMMUNOGENICITY OF A POLYVALENT MELANOMA ANTIGEN VACCINE IN HUMANS
    BYSTRYN, JC
    ORATZ, R
    HARRIS, MN
    ROSES, DF
    GOLOMB, FM
    SPEYER, JL
    CANCER, 1988, 61 (06) : 1065 - 1070
  • [25] Is the survival of melanoma patients receiving polyvalent melanoma cell vaccine linked to the human leukocyte antigen phenotype of patients? (vol 16, pg 1430, 1998)
    Hoon
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (06) : 2293 - 2293
  • [26] Prolonged survival of patients receiving active immunotherapy with canvaxin therapeutic polyvalent vaccine after complete resection of melanoma metastatic to regional lymph nodes
    Morton, DL
    Hsueh, EC
    Essner, R
    Foshag, LJ
    O'Day, SJ
    Bilchik, A
    Gupta, RK
    Hoon, DSB
    Ravindranath, M
    Nizze, JA
    Gammon, G
    Wanek, LA
    Wang, HJ
    Elashoff, RM
    ANNALS OF SURGERY, 2002, 236 (04) : 438 - 449
  • [27] Circulating melanoma cells and survival in metastatic melanoma
    Rao, C.
    Bui, T.
    Connelly, M.
    Doyle, G.
    Karydis, I.
    Middleton, M. R.
    Clack, G.
    Malone, M.
    Coumans, F. A. W.
    Terstappen, L. W. M. M.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2011, 38 (03) : 755 - 760
  • [28] UNUSUAL SURVIVAL PATTERNS OF PATIENTS WITH METASTATIC MELANOMA
    HENDRIX, RC
    CANCER, 1969, 24 (03) : 574 - &
  • [29] Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
    Hodi, F. Stephen
    O'Day, Steven J.
    McDermott, David F.
    Weber, Robert W.
    Sosman, Jeffrey A.
    Haanen, John B.
    Gonzalez, Rene
    Robert, Caroline
    Schadendorf, Dirk
    Hassel, Jessica C.
    Akerley, Wallace
    van den Eertwegh, Alfons J. M.
    Lutzky, Jose
    Lorigan, Paul
    Vaubel, Julia M.
    Linette, Gerald P.
    Hogg, David
    Ottensmeier, Christian H.
    Lebbe, Celeste
    Peschel, Christian
    Quirt, Ian
    Clark, Joseph I.
    Wolchok, Jedd D.
    Weber, Jeffrey S.
    Tian, Jason
    Yellin, Michael J.
    Nichol, Geoffrey M.
    Hoos, Axel
    Urba, Walter J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (08): : 711 - 723
  • [30] Improved survival in stage IB/II melanoma using Canvaxin™, a polyvalent cancer vaccine
    Faries, MB
    Foshag, LJ
    Essner, R
    Wanek, LA
    Morton, DL
    ANNALS OF SURGICAL ONCOLOGY, 2005, 12 (02) : S19 - S19
12345